Clinical Trial Update: A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 study comparing Imatinib alone versus Imatinib plus pegylated interferon in chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Pegasys (pegylated interferon alfa-2a) (pegylated interferon alfa-2a)

Snippet

Sponsor: Uppsala University | Conditions: Health Care Quality, Health Care Evaluation | Phase 2 | Status: COMPLETED